IBRX — Immunitybio Inc
In 2026 Q2, 4 of the 140 tracked hedge funds reported a position in Immunitybio Inc (IBRX), worth $13.54M combined. Over the quarter 2 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $9.01M | 0.01% | NEW |
| VanEck | $3.72M | 0.00% | NEW |
| IMC | $464.11K | 0.00% | -45.4% |
| Parvin | $350.20K | 0.28% | NO CHANGE |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.